13 results
6-K
EX-99.2
PHXM
PHAXIAM Therapeutics S.A.
24 May 23
Exemption Document Prepared In Connection with the Merger by Absorption of Pherecydes Pharma by Erytech Pharma
8:25am
on the Company’s laboratories. Although the Company believes that it meets its current legal obligations relating to the environment, non-compliance would expose … and anticipated circumstances and the economic environment. They thus serve as a basis for exercising the judgment required to determine the book value of assets
6-K
EX-99.1
PHXM
PHAXIAM Therapeutics S.A.
28 Apr 22
Asset Purchase Agreement
8:30am
thereof) or the protection of the environment, natural resources or endangered or threatened species, or (b) the presence of, exposure … the environment, including surface water, soil, groundwater, ambient air (indoor or outdoor), land surface or subsurface strata or within any building
6-K
EX-10.3
PHXM
PHAXIAM Therapeutics S.A.
16 Dec 21
Erytech Announces Presentation of Results of Expanded Access Program In All at 2021 Ash Annual Meeting and Acceptance of Two Abstracts at Asco Gi
5:23pm
to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface
6-K
EX-10.3
PHXM
PHAXIAM Therapeutics S.A.
3 May 21
ERYTECH Announces $30.0 Million
5:20pm
order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air
F-3
EX-1.2
7eiywwqa
21 Sep 20
Shelf registration (foreign)
5:26pm
6-K
EX-99.1
mhvkhu7b n8p90x
21 Sep 20
I. Certification of the Person Responsible for the Half-year Financial Report
6:09am
20-F
EX-4.3
fo136v
24 Apr 18
Annual report (foreign)
12:00am
20-F
wbgtn2iup7d227yz4r7
24 Apr 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next